Fosun Pharmaceutical (02196): FXR0906 injection approved to start clinical trials for the treatment of hypertriglyceridemia.

Zh tng cijng APP xn, F xng yyo (02196) gngb, jnr, gngs kngg zgng sf xng yyo chny fzhn (Shnzhn) yuxin gngs (yxi jinchng "F xng yyo (Shnzhn)") shudo guji yopn jind gunl j guny tngy FXR0906 zhshy (yxi jinchng "FXR0906") yngy zhlio gn gnl sn yng xizhng kizhn lnchng shyn de pzhn. F xng yyo (Shnzhn) n y tiojin jbi hu y zhnggu jngni kizhn gi yow de I q lnchng ynji.